Literature DB >> 4055725

The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis.

F Prelli, M Pras, B Frangione.   

Abstract

The amino acid sequence of human tissue amyloid P component (AP) extracted by a modified method from the spleen of a patient with primary idiopathic amyloidosis was determined. AP is a glycoprotein composed of a pair of noncovalently bound pentameric discs with a subunit size of 23-25 kDa. Each subunit consists of 204 residues, a single disulfide bridge linking Cys 36 to Cys 95, and a carbohydrate moiety attached to Asn 32. The precursor of AP is the serum amyloid protein (SAP). The primary structure of AP presented here differs from the amino acid sequence of SAP previously reported, but is identical to the amino acid sequence of mature SAP deduced from the nucleotide sequence of complementary DNA clones. It shares 52% homology with the amended sequence of human C-reactive protein, an acute phase protein, and 68% homology with the Syrian hamster "female protein," another acute phase protein whose response is modulated by sex steroids. AP/SAP, C-reactive protein, and female protein belong to a family of plasma proteins called pentraxins and their considerable sequence homology is probably the result of gene duplication. Neither the physiological function of AP nor its possible pathological role in amyloidosis are yet known.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Examining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDI-MS.

Authors:  Noah G Weiss; Jason W Jarvis; Randall W Nelson; Mark A Hayes
Journal:  Proteomics       Date:  2010-12-01       Impact factor: 3.984

2.  Mouse C-reactive protein. Generation of cDNA clones, structural analysis, and induction of mRNA during inflammation.

Authors:  A S Whitehead; K Zahedi; M Rits; R F Mortensen; J M Lelias
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  Rat serum amyloid P component. Analysis of cDNA sequence and gene expression.

Authors:  S B Dowton; S D McGrew
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

4.  Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.

Authors:  P N Hawkins; G A Tennent; P Woo; M B Pepys
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

5.  Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

Authors:  P N Hawkins; R Wootton; M B Pepys
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Immunodetection of the amyloid P component in Alzheimer's disease.

Authors:  T Duong; E C Pommier; A B Scheibel
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.

Authors:  P D Gorevic; P C Munoz; T T Casey; C R DiRaimondo; W J Stone; F C Prelli; M M Rodrigues; M D Poulik; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

Authors:  M B Pepys; T W Rademacher; S Amatayakul-Chantler; P Williams; G E Noble; W L Hutchinson; P N Hawkins; S R Nelson; J R Gallimore; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Studies of the structure and binding properties of hamster female protein.

Authors:  G A Tennent; M L Baltz; G D Osborn; P J Butler; G E Noble; P N Hawkins; M B Pepys
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.

Authors:  C M Kinoshita; A T Gewurz; J N Siegel; S C Ying; T E Hugli; J E Coe; R K Gupta; R Huckman; H Gewurz
Journal:  Protein Sci       Date:  1992-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.